FOXO3 and lip and oral cavity carcinoma: Similarly, Lee et al. [12] showed that pitavastatin promotes FOXO3a nuclear transcription mainly by inhibiting AKT and activating AMPK, resulting in apoptosis in oral cancer SCC15 cells.